These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30658195)

  • 1. Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role.
    Chen Y; Wang X; Yang C; Su X; Yang W; Dai Y; Han H; Jiang J; Lu L; Wang H; Chen Q; Jin W
    Atherosclerosis; 2019 Feb; 281():78-88. PubMed ID: 30658195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia.
    Kojima M; Ozawa N; Mori Y; Takahashi Y; Watanabe-Kominato K; Shirai R; Watanabe R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    Thromb Haemost; 2018 Jan; 118(1):182-194. PubMed ID: 29304538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease.
    Lu L; Wang YN; Li MC; Wang HB; Pu LJ; Niu WQ; Meng H; Yang EL; Zhang RY; Zhang Q; Zhao Q; Chen QJ; De Caterina R; Shen WF
    Eur Heart J; 2012 Sep; 33(18):2297-306. PubMed ID: 22645192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of vasostatin-1 against atherogenesis.
    Sato Y; Watanabe R; Uchiyama N; Ozawa N; Takahashi Y; Shirai R; Sato K; Mori Y; Matsuyama T; Ishibashi-Ueda H; Hirano T; Watanabe T
    Clin Sci (Lond); 2018 Dec; 132(23):2493-2507. PubMed ID: 30401690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.
    Ganbaatar B; Fukuda D; Salim HM; Nishimoto S; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Sata M
    Atherosclerosis; 2018 Aug; 275():124-132. PubMed ID: 29902700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.
    Zhang YH; Zhang YH; Dong XF; Hao QQ; Zhou XM; Yu QT; Li SY; Chen X; Tengbeh AF; Dong B; Zhang Y
    Inflamm Res; 2015 Apr; 64(3-4):253-60. PubMed ID: 25721616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN.
    Hu YW; Guo FX; Xu YJ; Li P; Lu ZF; McVey DG; Zheng L; Wang Q; Ye JH; Kang CM; Wu SG; Zhao JJ; Ma X; Yang Z; Fang FC; Qiu YR; Xu BM; Xiao L; Wu Q; Wu LM; Ding L; Webb TR; Samani NJ; Ye S
    J Clin Invest; 2019 Mar; 129(3):1115-1128. PubMed ID: 30589415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice.
    Van der Veken B; De Meyer GRY; Martinet W
    Vascul Pharmacol; 2018 Jan; 100():34-40. PubMed ID: 29079346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin.
    Angelone T; Quintieri AM; Pasqua T; Gentile S; Tota B; Mahata SK; Cerra MC
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(2):H431-42. PubMed ID: 22058158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidoglycan Recognition Protein 1 Attenuates Atherosclerosis by Suppressing Endothelial Cell Adhesion.
    Jin Y; Huang H; Shu X; Liu Z; Lu L; Dai Y; Wu Z
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):615-621. PubMed ID: 34269701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Semaphorin 7A Upregulation by Disturbed Flow Promotes Atherosclerosis Through Endothelial β1 Integrin.
    Hu S; Liu Y; You T; Heath J; Xu L; Zheng X; Wang A; Wang Y; Li F; Yang F; Cao Y; Zhang H; van Gils JM; van Zonneveld AJ; Jo H; Wu Q; Zhang Y; Tang C; Zhu L
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):335-343. PubMed ID: 29269512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).
    Jitpean S; Stridsberg M; Pettersson A; Höglund OV; Holst BS; Hagman R
    BMC Vet Res; 2015 Jan; 11():14. PubMed ID: 25636335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels and potential roles of catestatin in patients with coronary heart disease.
    Liu L; Ding W; Zhao F; Shi L; Pang Y; Tang C
    Scand Cardiovasc J; 2013 Aug; 47(4):217-24. PubMed ID: 23688154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating PGLYRP1 Levels as a Potential Biomarker for Coronary Artery Disease and Heart Failure.
    Han Y; Hua S; Chen Y; Yang W; Zhao W; Huang F; Qiu Z; Yang C; Jiang J; Su X; Yang K; Jin W
    J Cardiovasc Pharmacol; 2021 May; 77(5):578-585. PubMed ID: 33760799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catestatin as a Target for Treatment of Inflammatory Diseases.
    Muntjewerff EM; Dunkel G; Nicolasen MJT; Mahata SK; van den Bogaart G
    Front Immunol; 2018; 9():2199. PubMed ID: 30337922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.